Titre : Atrophie parodontale

Atrophie parodontale : Questions médicales fréquentes

Termes MeSH sélectionnés :

Cellular Reprogramming
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Atrophie parodontale : Questions médicales les plus fréquentes", "headline": "Atrophie parodontale : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Atrophie parodontale : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-09", "dateModified": "2025-04-04", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Atrophie parodontale" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Maladies parodontales", "url": "https://questionsmedicales.fr/mesh/D010510", "about": { "@type": "MedicalCondition", "name": "Maladies parodontales", "code": { "@type": "MedicalCode", "code": "D010510", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C07.465.714" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Résorption alvéolaire", "alternateName": "Alveolar Bone Loss", "url": "https://questionsmedicales.fr/mesh/D016301", "about": { "@type": "MedicalCondition", "name": "Résorption alvéolaire", "code": { "@type": "MedicalCode", "code": "D016301", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C07.465.714.354.500" } } }, { "@type": "MedicalWebPage", "name": "Récession gingivale", "alternateName": "Gingival Recession", "url": "https://questionsmedicales.fr/mesh/D005889", "about": { "@type": "MedicalCondition", "name": "Récession gingivale", "code": { "@type": "MedicalCode", "code": "D005889", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C07.465.714.354.625" } } }, { "@type": "MedicalWebPage", "name": "Perte d'attache parodontale", "alternateName": "Periodontal Attachment Loss", "url": "https://questionsmedicales.fr/mesh/D017622", "about": { "@type": "MedicalCondition", "name": "Perte d'attache parodontale", "code": { "@type": "MedicalCode", "code": "D017622", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C07.465.714.354.750" } } } ], "about": { "@type": "MedicalCondition", "name": "Atrophie parodontale", "alternateName": "Periodontal Atrophy", "code": { "@type": "MedicalCode", "code": "D055093", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Frederik Barkhof", "url": "https://questionsmedicales.fr/author/Frederik%20Barkhof", "affiliation": { "@type": "Organization", "name": "From the Department of Neurology and Alzheimer Center (C.G., Y.A.L.P., P.S., W.M.v.d.F., R.O.), and Departments of Radiology and Nuclear Medicine (F.B.) and Epidemiology and Biostatistics (W.M.v.d.F.), Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, the Netherlands; Department of Electrical and Computer Engineering (B.T.T.Y., X.Z., N.S.), Clinical Imaging Research Centre, N1 Institute for Health and Memory Networks Program, National University of Singapore; Montreal Neurological Institute (J.W.V.), McGill University, Montreal, Canada; Computer Science and Artificial Intelligence Laboratory (X.Z.), Massachusetts Institute of Technology, Cambridge; Department of Neurology and Neurological Sciences (E.C.M.), Stanford University, CA; Departments of Neurology, Radiology and Biomedical Imaging (B.L.M., H.J.R., R.L.J., G.D.R.), University of California, San Francisco; Institutes of Neurology & Healthcare Engineering (F.B.), University College London, UK; and Clinical Memory Research Unit (R.O.), Lund University, Sweden." } }, { "@type": "Person", "name": "Maria Teresa Pellecchia", "url": "https://questionsmedicales.fr/author/Maria%20Teresa%20Pellecchia", "affiliation": { "@type": "Organization", "name": "Department of Medicine, Surgery and Dentistry \"Scuola Medica Salernitana\", Neuroscience Section, University of Salerno, Baronissi, SA, Italy." } }, { "@type": "Person", "name": "Iva Stankovic", "url": "https://questionsmedicales.fr/author/Iva%20Stankovic", "affiliation": { "@type": "Organization", "name": "Neurology Clinic, Clinical Center of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia." } }, { "@type": "Person", "name": "Gregor K Wenning", "url": "https://questionsmedicales.fr/author/Gregor%20K%20Wenning", "affiliation": { "@type": "Organization", "name": "Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria." } }, { "@type": "Person", "name": "Klaus Seppi", "url": "https://questionsmedicales.fr/author/Klaus%20Seppi", "affiliation": { "@type": "Organization", "name": "Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "SARS-CoV-2 viral genes Nsp6, Nsp8, and M compromise cellular ATP levels to impair survival and function of human pluripotent stem cell-derived cardiomyocytes.", "datePublished": "2023-09-13", "url": "https://questionsmedicales.fr/article/37705046", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s13287-023-03485-3" } }, { "@type": "ScholarlyArticle", "name": "Veillonella parvula promotes the proliferation of lung adenocarcinoma through the nucleotide oligomerization domain 2/cellular communication network factor 4/nuclear factor kappa B pathway.", "datePublished": "2023-07-14", "url": "https://questionsmedicales.fr/article/37452162", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s12672-023-00748-6" } }, { "@type": "ScholarlyArticle", "name": "Humoral and cellular immune responses eleven months after the third dose of BNT162b2 an mRNA-based COVID-19 vaccine in people with HIV - a prospective observational cohort study.", "datePublished": "2023-06-16", "url": "https://questionsmedicales.fr/article/37331161", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.ebiom.2023.104661" } }, { "@type": "ScholarlyArticle", "name": "Discovery of New 2-Phenylamino-3-acyl-1,4-naphthoquinones as Inhibitors of Cancer Cells Proliferation: Searching for Intra-Cellular Targets Playing a Role in Cancer Cells Survival.", "datePublished": "2023-05-24", "url": "https://questionsmedicales.fr/article/37298798", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/molecules28114323" } }, { "@type": "ScholarlyArticle", "name": "New Platform for Label-Free, Proximal Cellular Pharmacodynamic Assays: Identification of Glutaminase Inhibitors Using Infrared Matrix-Assisted Laser Desorption Electrospray Ionization Mass Spectrometry.", "datePublished": "2023-04-12", "url": "https://questionsmedicales.fr/article/37043689", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1021/acschembio.3c00087" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Maladies du système stomatognathique", "item": "https://questionsmedicales.fr/mesh/D009057" }, { "@type": "ListItem", "position": 3, "name": "Maladies de la bouche", "item": "https://questionsmedicales.fr/mesh/D009059" }, { "@type": "ListItem", "position": 4, "name": "Maladies parodontales", "item": "https://questionsmedicales.fr/mesh/D010510" }, { "@type": "ListItem", "position": 5, "name": "Atrophie parodontale", "item": "https://questionsmedicales.fr/mesh/D055093" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Atrophie parodontale - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Atrophie parodontale", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-07", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Atrophie parodontale", "description": "Comment diagnostiquer l'atrophie parodontale ?\nQuels tests sont utilisés pour évaluer l'atrophie ?\nQuels signes cliniques indiquent l'atrophie ?\nL'atrophie parodontale est-elle réversible ?\nQuel rôle joue l'historique médical dans le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D055093?mesh_terms=Cellular+Reprogramming&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Atrophie parodontale", "description": "Quels sont les symptômes de l'atrophie parodontale ?\nL'atrophie parodontale cause-t-elle des douleurs ?\nPeut-on avoir des gencives qui saignent ?\nComment l'atrophie affecte-t-elle l'apparence des dents ?\nY a-t-il un lien entre l'atrophie et la sensibilité dentaire ?", "url": "https://questionsmedicales.fr/mesh/D055093?mesh_terms=Cellular+Reprogramming&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Atrophie parodontale", "description": "Comment prévenir l'atrophie parodontale ?\nQuel rôle joue le brossage des dents ?\nLes produits de rinçage buccal sont-ils utiles ?\nL'alimentation influence-t-elle la santé parodontale ?\nFumer affecte-t-il la santé parodontale ?", "url": "https://questionsmedicales.fr/mesh/D055093?mesh_terms=Cellular+Reprogramming&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Atrophie parodontale", "description": "Quels traitements sont disponibles pour l'atrophie parodontale ?\nLa chirurgie est-elle nécessaire pour traiter l'atrophie ?\nLes antibiotiques sont-ils utilisés dans le traitement ?\nComment la thérapie au laser aide-t-elle ?\nLes traitements sont-ils douloureux ?", "url": "https://questionsmedicales.fr/mesh/D055093?mesh_terms=Cellular+Reprogramming&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Atrophie parodontale", "description": "Quelles complications peuvent survenir avec l'atrophie ?\nL'atrophie parodontale peut-elle affecter la santé générale ?\nY a-t-il un risque accru de diabète ?\nComment l'atrophie affecte-t-elle la qualité de vie ?\nLes infections parodontales peuvent-elles se propager ?", "url": "https://questionsmedicales.fr/mesh/D055093?mesh_terms=Cellular+Reprogramming&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Atrophie parodontale", "description": "Quels sont les principaux facteurs de risque ?\nL'âge influence-t-il le risque d'atrophie ?\nLe stress a-t-il un impact sur la santé parodontale ?\nLes maladies auto-immunes sont-elles un facteur de risque ?\nUne alimentation déséquilibrée influence-t-elle le risque ?", "url": "https://questionsmedicales.fr/mesh/D055093?mesh_terms=Cellular+Reprogramming&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer l'atrophie parodontale ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic se fait par un examen clinique et des radiographies dentaires." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer l'atrophie ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des sondages parodontal et des radiographies sont utilisés pour évaluer la perte osseuse." } }, { "@type": "Question", "name": "Quels signes cliniques indiquent l'atrophie ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les signes incluent la récession gingivale et la mobilité dentaire." } }, { "@type": "Question", "name": "L'atrophie parodontale est-elle réversible ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Non, l'atrophie parodontale est généralement irréversible, mais peut être stabilisée." } }, { "@type": "Question", "name": "Quel rôle joue l'historique médical dans le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'historique médical aide à identifier les facteurs de risque et les antécédents de maladies." } }, { "@type": "Question", "name": "Quels sont les symptômes de l'atrophie parodontale ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des gencives enflammées, des douleurs et une mauvaise haleine." } }, { "@type": "Question", "name": "L'atrophie parodontale cause-t-elle des douleurs ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut provoquer des douleurs lors de la mastication ou de la pression sur les dents." } }, { "@type": "Question", "name": "Peut-on avoir des gencives qui saignent ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les gencives peuvent saigner lors du brossage ou de l'utilisation de fil dentaire." } }, { "@type": "Question", "name": "Comment l'atrophie affecte-t-elle l'apparence des dents ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut entraîner un aspect plus long des dents en raison de la récession gingivale." } }, { "@type": "Question", "name": "Y a-t-il un lien entre l'atrophie et la sensibilité dentaire ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'atrophie peut augmenter la sensibilité dentaire aux aliments chauds ou froids." } }, { "@type": "Question", "name": "Comment prévenir l'atrophie parodontale ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Une bonne hygiène bucco-dentaire et des visites régulières chez le dentiste sont essentielles." } }, { "@type": "Question", "name": "Quel rôle joue le brossage des dents ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Le brossage régulier aide à éliminer la plaque dentaire et à prévenir les maladies parodontales." } }, { "@type": "Question", "name": "Les produits de rinçage buccal sont-ils utiles ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains rince-bouche antibactériens peuvent aider à réduire l'inflammation gingivale." } }, { "@type": "Question", "name": "L'alimentation influence-t-elle la santé parodontale ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation équilibrée riche en vitamines et minéraux favorise la santé des gencives." } }, { "@type": "Question", "name": "Fumer affecte-t-il la santé parodontale ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme augmente le risque de maladies parodontales et d'atrophie." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour l'atrophie parodontale ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent le détartrage, le surfaçage radiculaire et la chirurgie parodontale." } }, { "@type": "Question", "name": "La chirurgie est-elle nécessaire pour traiter l'atrophie ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "La chirurgie peut être nécessaire dans les cas avancés pour restaurer le tissu parodontal." } }, { "@type": "Question", "name": "Les antibiotiques sont-ils utilisés dans le traitement ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antibiotiques peuvent être prescrits pour traiter les infections parodontales." } }, { "@type": "Question", "name": "Comment la thérapie au laser aide-t-elle ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "La thérapie au laser peut réduire l'inflammation et favoriser la guérison des tissus parodontal." } }, { "@type": "Question", "name": "Les traitements sont-ils douloureux ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements peuvent causer un certain inconfort, mais des anesthésiques sont utilisés." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec l'atrophie ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent la perte de dents, des infections et des problèmes de mastication." } }, { "@type": "Question", "name": "L'atrophie parodontale peut-elle affecter la santé générale ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des études montrent un lien entre les maladies parodontales et des problèmes systémiques." } }, { "@type": "Question", "name": "Y a-t-il un risque accru de diabète ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les maladies parodontales peuvent aggraver le contrôle glycémique chez les diabétiques." } }, { "@type": "Question", "name": "Comment l'atrophie affecte-t-elle la qualité de vie ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut entraîner des douleurs, des difficultés à manger et une baisse de l'estime de soi." } }, { "@type": "Question", "name": "Les infections parodontales peuvent-elles se propager ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les infections peuvent se propager à d'autres parties du corps, augmentant les risques." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les principaux facteurs incluent le tabagisme, le diabète, et une mauvaise hygiène bucco-dentaire." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque d'atrophie ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le risque d'atrophie parodontale augmente avec l'âge en raison de l'usure des tissus." } }, { "@type": "Question", "name": "Le stress a-t-il un impact sur la santé parodontale ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress peut affaiblir le système immunitaire et aggraver les maladies parodontales." } }, { "@type": "Question", "name": "Les maladies auto-immunes sont-elles un facteur de risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines maladies auto-immunes peuvent augmenter le risque d'atrophie parodontale." } }, { "@type": "Question", "name": "Une alimentation déséquilibrée influence-t-elle le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation pauvre en nutriments peut affaiblir les gencives et favoriser l'atrophie." } } ] } ] }

Sources (10000 au total)

SARS-CoV-2 viral genes Nsp6, Nsp8, and M compromise cellular ATP levels to impair survival and function of human pluripotent stem cell-derived cardiomyocytes.

Cardiovascular complications significantly augment the overall COVID-19 mortality, largely due to the susceptibility of human cardiomyocytes (CMs) to SARS-CoV-2 virus. SARS-CoV-2 virus encodes 27 gene... CMs were derived from human pluripotent stem cells (hPSCs), including human embryonic stem cells and induced pluripotent stem cells, using 2D and 3D differentiation methods. We overexpressed Nsp6, M, ... Nsp6, Nsp8, and M globally perturb the transcriptome and proteome of hPSC-CMs. SARS-CoV-2 infection and the overexpression of Nsp6, Nsp8, or M coherently upregulated genes associated with apoptosis an... Overall, our findings uncover the extensive damaging effects of Nsp6, Nsp8, and M on hPSC-CMs, underlining the crucial role of ATP homeostasis in CM death and functional abnormalities induced by these...

Humoral and cellular immune responses eleven months after the third dose of BNT162b2 an mRNA-based COVID-19 vaccine in people with HIV - a prospective observational cohort study.

We investigated long-term durability of humoral and cellular immune responses to third dose of BNT162b2 in people with HIV (PWH) and controls.... In 378 PWH with undetectable viral replication and 224 matched controls vaccinated with three doses of BNT162b2, we measured IgG-antibodies against the receptor binding domain of SARS-CoV-2 spike prot... Before the third dose the concentration of SARS-CoV-2 antibodies was lower in PWH than in controls (unadjusted geometric mean ratio (GMR): 0.68 (95% CI: 0.54-0.86, p = 0.002). We observed no differenc... We found no differences in antibody concentrations or cellular response between PWH and controls up to eleven months after third dose of BNT162b2. Our findings indicate that PWH with undetectable vira... This work was funded by the Novo Nordisk Foundation (NFF205A0063505, NNF20SA0064201), the Carlsberg Foundation (CF20-476 0045), the Svend Andersen Research Foundation (SARF2021), and Bio- and Genome B...

Discovery of New 2-Phenylamino-3-acyl-1,4-naphthoquinones as Inhibitors of Cancer Cells Proliferation: Searching for Intra-Cellular Targets Playing a Role in Cancer Cells Survival.

A series of 2-phenylamino-3-acyl-1,4-naphtoquinones were evaluated regarding their in vitro antiproliferative activities using DU-145, MCF-7 and T24 cancer cells. Such activities were discussed in ter...

New Platform for Label-Free, Proximal Cellular Pharmacodynamic Assays: Identification of Glutaminase Inhibitors Using Infrared Matrix-Assisted Laser Desorption Electrospray Ionization Mass Spectrometry.

Cellular pharmacodynamic assays are crucial aspects of lead optimization programs in drug discovery. These assays are sometimes difficult to develop, oftentimes distal from the target and frequently l...

Longitudinal Analysis of Humoral and Cellular Immune Response Following SARS-CoV-2 Vaccination Supports Utilizing Point-Of-Care Tests to Enhance COVID-19 Booster Uptake.

Individuals with weaker neutralizing responses show reduced protection with SARS-CoV-2 variants. Booster vaccines are recommended for vaccinated individuals, but the uptake is low. We present the feas... SARS-CoV-2 point-of-care antibody tests are valuable and easy-to-access tools to inform inadequate humoral immunity and to support informed decision-making regarding the current and future booster vac...

Hybridization of triphenylamine to BODIPY dyes at the 3,5,8-positions: A facile strategy to construct near infra-red aggregation-induced emission luminogens with intramolecular charge transfer for cellular imaging.

A series of five BODIPY derivatives with triarylamine (TPA) moieties on their 3-, 5-, or 8-positions were reported, which showed wide-range fluorescence emissions across red and near infrared regions ...